MX2023002686A - Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. - Google Patents
Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos.Info
- Publication number
- MX2023002686A MX2023002686A MX2023002686A MX2023002686A MX2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A
- Authority
- MX
- Mexico
- Prior art keywords
- oxacycloalkyl
- sulphamoyl
- moiety
- containing alkyl
- urea derivatives
- Prior art date
Links
- OJXASOYYODXRPT-UHFFFAOYSA-N sulfamoylurea Chemical class NC(=O)NS(N)(=O)=O OJXASOYYODXRPT-UHFFFAOYSA-N 0.000 title 1
- 108010034143 Inflammasomes Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000011594 Autoinflammatory disease Diseases 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 102000039996 IL-1 family Human genes 0.000 abstract 1
- 108091069196 IL-1 family Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023002686A true MX2023002686A (es) | 2023-04-03 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023002686A MX2023002686A (es) | 2020-09-04 | 2021-09-03 | Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP2023540733A (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| SI3983387T1 (sl) | 2019-06-12 | 2024-09-30 | NodThera Limited | Derivati sulfoniluree in njihove uporabe |
| ES3056339T3 (en) | 2019-06-12 | 2026-02-19 | Nodthera Ltd | Sulfonylurea derivatives and uses thereof |
| WO2025104244A1 (en) * | 2023-11-17 | 2025-05-22 | NodThera Limited | Methods of preparing urea derivatives |
| AU2024381716A1 (en) | 2023-11-17 | 2026-05-14 | NodThera Limited | Forms of urea derivatives and related uses |
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| JP3573757B2 (ja) | 1997-01-29 | 2004-10-06 | ファイザー・インク | スルホニルウレア誘導体、およびインターロイキン−１の活性を制御する上でのスルホニルウレア誘導体の使用 |
| HUE055755T2 (hu) * | 2015-02-16 | 2021-12-28 | Univ Queensland | Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk |
| HUE066566T2 (hu) | 2017-07-24 | 2024-08-28 | Novartis Ag | Vegyületek és készítmények NLRP aktivitással összefüggõ állapotok kezelésére |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| CN112672995A (zh) * | 2018-08-15 | 2021-04-16 | 英夫拉索姆有限公司 | 新型磺酰胺脲化合物 |
-
2021
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 JP JP2023514910A patent/JP2023540733A/ja active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022051582A1 (en) | 2022-03-10 |
| IL301055A (en) | 2023-05-01 |
| KR20230061505A (ko) | 2023-05-08 |
| AU2021336518A1 (en) | 2023-03-23 |
| TW202229265A (zh) | 2022-08-01 |
| US20240043410A1 (en) | 2024-02-08 |
| AR123435A1 (es) | 2022-11-30 |
| BR112023003792A2 (pt) | 2023-03-28 |
| JP2023540733A (ja) | 2023-09-26 |
| EP4208459A1 (en) | 2023-07-12 |
| CA3191410A1 (en) | 2022-03-10 |
| CN116783184A (zh) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202000425B (en) | Selective inhibitors of nlrp3 inflammasome | |
| MX2020006399A (es) | Derivados de sulfonil urea. | |
| MX2025011899A (es) | Compuestos de pirido[4,3-d]pirimidina | |
| BR112023003792A2 (pt) | Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos | |
| EP4537900A3 (en) | Compounds for inhibiting nlrp3 and uses thereof | |
| MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
| MX2024000234A (es) | Inhibidores del inflamasoma nlrp3. | |
| EA201992152A1 (ru) | Химические соединения | |
| MX2020009738A (es) | Derivados de imidazolidin-2-ona sustituidos como inhibidores de prmt5. | |
| UA86614C2 (ru) | Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата | |
| WO2004071400A3 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| JOP20230252A1 (ar) | مشتقات فسفورية كمثبطات sos1 جديدة | |
| MX2025011886A (es) | Derivados biciclicos semisaturados y usos relacionados | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| WO2025014877A3 (en) | Triazolo wrn inhibitors | |
| MX2025000635A (es) | Compuestos cíclicos y métodos de utilización de estos | |
| MX2026000683A (es) | Derivados de heteroarilo sustituidos con diaminociclopentilo, su uso y su metodo de preparacion | |
| CO2024015371A2 (es) | Derivados de oxoindolinil amida para inhibir nlrp3 y usos de los mismos | |
| MX2023012039A (es) | Compuestos bicíclicos fusionados sustituidos como inhibidores de parp y uso de estos. | |
| MX2025001865A (es) | Compuestos de piridinona sustituida como inhibidores de cbl-b | |
| MX2025010952A (es) | Derivados de amida para inhibir el gen nlrp3 y usos de los mismos | |
| MX2021008930A (es) | Derivados de carbamato y sus usos. | |
| WO2024086789A3 (en) | Mutant pi3k-alpha inhibitors and their use as pharmaceuticals |